Chronic, Acute and Neuropathic Pain - GPCR and Nerve Growth Factor-Based Therapies Offer Strong Potential in Difficult-to-Treat Subtypes; New Report Launched
Market Research Reports, Inc. has announced the addition of “Frontier Pharma: Chronic, Acute and Neuropathic Pain - GPCR and Nerve Growth Factor-based therapies offer strong potential in difficult-to-treat subtypes” research report to their website www.MarketResearchReports.com
View full press release